EZZ Life Science Holdings Limited

ASX:EZZ Stock Report

Market Cap: AU$134.3m

EZZ Life Science Holdings Future Growth

Future criteria checks 4/6

EZZ Life Science Holdings is forecast to grow earnings and revenue by 17.9% and 14.9% per annum respectively. EPS is expected to grow by 16.9% per annum. Return on equity is forecast to be 23.2% in 3 years.

Key information

17.9%

Earnings growth rate

16.9%

EPS growth rate

Life Sciences earnings growth20.4%
Revenue growth rate14.9%
Future return on equity23.2%
Analyst coverage

Low

Last updated08 Nov 2024

Recent future growth updates

Recent updates

EZZ Life Science Holdings Limited (ASX:EZZ) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Nov 04
EZZ Life Science Holdings Limited (ASX:EZZ) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

EZZ Life Science Holdings Limited's (ASX:EZZ) Shares Leap 41% Yet They're Still Not Telling The Full Story

Aug 28
EZZ Life Science Holdings Limited's (ASX:EZZ) Shares Leap 41% Yet They're Still Not Telling The Full Story

EZZ Life Science Holdings Limited (ASX:EZZ) Stock Catapults 29% Though Its Price And Business Still Lag The Market

Jun 05
EZZ Life Science Holdings Limited (ASX:EZZ) Stock Catapults 29% Though Its Price And Business Still Lag The Market

There's No Escaping EZZ Life Science Holdings Limited's (ASX:EZZ) Muted Earnings Despite A 28% Share Price Rise

Apr 02
There's No Escaping EZZ Life Science Holdings Limited's (ASX:EZZ) Muted Earnings Despite A 28% Share Price Rise

Here's Why We Think EZZ Life Science Holdings (ASX:EZZ) Is Well Worth Watching

Feb 09
Here's Why We Think EZZ Life Science Holdings (ASX:EZZ) Is Well Worth Watching

EZZ Life Science Holdings Limited's (ASX:EZZ) Share Price Is Matching Sentiment Around Its Earnings

Oct 18
EZZ Life Science Holdings Limited's (ASX:EZZ) Share Price Is Matching Sentiment Around Its Earnings

EZZ Life Science Holdings' (ASX:EZZ) Promising Earnings May Rest On Soft Foundations

Mar 06
EZZ Life Science Holdings' (ASX:EZZ) Promising Earnings May Rest On Soft Foundations

Calculating The Fair Value Of EZZ Life Science Holdings Limited (ASX:EZZ)

Nov 22
Calculating The Fair Value Of EZZ Life Science Holdings Limited (ASX:EZZ)

Earnings and Revenue Growth Forecasts

ASX:EZZ - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20271091212121
6/30/2026991010101
6/30/2025908881
6/30/202466766N/A
3/31/202455555N/A
12/31/202344344N/A
9/30/202340444N/A
6/30/202337444N/A
3/31/202331322N/A
12/31/202224311N/A
9/30/202219211N/A
6/30/202215122N/A
3/31/202215111N/A
12/31/202116100N/A
9/30/202119100N/A
6/30/202122200N/A
3/31/202122211N/A
12/31/202021222N/A
9/30/202020222N/A
6/30/202018233N/A
6/30/201911100N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EZZ's forecast earnings growth (17.9% per year) is above the savings rate (2.6%).

Earnings vs Market: EZZ's earnings (17.9% per year) are forecast to grow faster than the Australian market (12.6% per year).

High Growth Earnings: EZZ's earnings are forecast to grow, but not significantly.

Revenue vs Market: EZZ's revenue (14.9% per year) is forecast to grow faster than the Australian market (5.8% per year).

High Growth Revenue: EZZ's revenue (14.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: EZZ's Return on Equity is forecast to be high in 3 years time (23.2%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 02:54
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EZZ Life Science Holdings Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullLodge Partners Pty Ltd.
Chris KallosMST Financial Services Pty Limited